Page 78 - Marcus Arduini Monzo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marcus arduini monzo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marcus Arduini Monzo Today - Breaking & Trending Today

Trending With Marcus: First trailer drops for upcoming Kevin Costner Western epic

On Tuesday’s Trending With Marcus on the WGN Morning News, Marcus Leshock gives a look at the trailer that just dropped for Kevin Costner’s upcoming Western epic. Costner’s four-part epic, “Horizon: An American Saga,” will debut in theaters this summer with a dual release of the first two parts. Chapter 1 is scheduled to hit […] ....

United States , Lori Loughlin , John Stamos , Marcus Leshock , Kevin Costner , Warner Bros , Trending With Marcus , Civil War , Dave Coulier , Full House Rewind , Aunt Becky , Uncle Joey , Uncle Jesse , Kevin Costner , Wgn Morning News , Western Epic , Lori Loughlin , American Saga , Dave Coulier ,

Arcus Biosciences (NYSE:RCUS) Rating Reiterated by Wedbush

Wedbush reiterated their outperform rating on shares of Arcus Biosciences (NYSE:RCUS – Free Report) in a research report sent to investors on Thursday, Marketbeat Ratings reports. The brokerage currently has a $30.00 target price on the stock. Wedbush also issued estimates for Arcus Biosciences’ FY2028 earnings at $1.87 EPS. A number of other research analysts […] ....

United States , Jennifer Jarrett , Arcus Biosciences Inc , Gilead Sciences Inc , Securities Exchange Commission , Arcus Biosciences Company Profile , Cantor Fitzgerald , Pricet Rowe Associates Inc , Capital Partners , Vanguard Group Inc , Morgan Stanley , Arcus Biosciences , Free Report , Marketbeat Ratings , Arcus Bioscience , Moderate Buy , Get Free Report , Gilead Sciences , Exchange Commission , Employees Retirement System , Public Sector Pension Investment Board , Sector Pension Investment Board , Arcus Biosciences Daily , Nyse Rcus , Reiterated Rating ,

Arcus Biosciences (NYSE:RCUS) Earns "Outperform" Rating from Wedbush

Wedbush reiterated their outperform rating on shares of Arcus Biosciences (NYSE:RCUS – Free Report) in a research note released on Thursday, MarketBeat reports. Wedbush currently has a $30.00 price objective on the stock. Wedbush also issued estimates for Arcus Biosciences’ FY2028 earnings at $1.87 EPS. Other equities analysts have also recently issued research reports about […] ....

United States , Robertc Goeltz , Morgan Stanley , Bluepath Capital Management , Arcus Biosciences Company Profile , Cantor Fitzgerald , Gilead Sciences Inc , Arcus Biosciences Inc , Osaic Holdings Inc , Securities Exchange Commission , Arcus Biosciences , Free Report , Arcus Bioscience , Moderate Buy , Get Free Report , Gilead Sciences , Exchange Commission , Path Capital Management , Employees Retirement System , Strs Ohio , Arcus Biosciences Daily , Nyse Rcus , Reiterated Rating ,

The Marcus Co. (MCS) To Go Ex-Dividend on March 1st

The Marcus Co. (NYSE:MCS – Get Free Report) declared a quarterly dividend on Thursday, February 22nd, Wall Street Journal reports. Shareholders of record on Monday, March 4th will be given a dividend of 0.07 per share on Friday, March 15th. This represents a $0.28 annualized dividend and a yield of 1.91%. The ex-dividend date of […] ....

United States , Marcus Company Profile , Morgan Dempsey Capital Management , Harbour Investments Inc , Marcus Co , Tower Research Capital , Marcus Corporation , Get Free Report , Wall Street Journal , Retirement System , Research Capital , Dempsey Capital Management , Funset Boulevard , Big Screen Bistro , Big Screen Bistro Express , Movie Tavern , Marcus Daily , Nyse Mcs , Consumer Discretionary ,

Arcus Biosciences (NYSE:RCUS) Issues Earnings Results

Arcus Biosciences (NYSE:RCUS – Get Free Report) released its earnings results on Wednesday. The company reported ($1.08) EPS for the quarter, beating the consensus estimate of ($1.09) by $0.01, Briefing.com reports. Arcus Biosciences had a negative net margin of 262.39% and a negative return on equity of 54.63%. The company had revenue of $31.00 million […] ....

United States , Juanc Jaen , Robertc Goeltz , Metlife Investment Management , Arcus Biosciences Inc , Securities Exchange Commission , Vanguard Group Inc , Cantor Fitzgerald , Dimensional Fund Advisors , Lazard Asset Management , Morgan Stanley , Arcus Biosciences , Get Free Report , President Juan , Exchange Commission , Life Investment Management , Fund Advisors , Arcus Biosciences Daily , Nyse Rcus ,